LD-2 disclosure · 4th Quarter - Report
INFUSION PROVIDERS ALLIANCE
Client
- Description
- Association representing infusion drug providers.
- Location
- Delaware · United States of America
Registrant
- Description
- Consulting
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
2 issuesMedicare/Medicaid
Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. HR 5391, S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act. Issues related to White Bagging. Issues related to virtual supervision of infusion drugs. Issues related to down coding of certain complex Part B drugs by regional Medicare Administrative Contractors (MACs). Extension of certain telehealth flexibilities included in H.R. 10545 the American Relief Act, 2025 Issues related to MACRA Reform including HR 2474 - Strengthening Medicare for Patients and Providers Act. Issues related to physician payment included in H.R.10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act.
LobbyistsJOHN MCMANUS · ms LAWREN D GEER · ALEX WHALEN
Covered position (JOHN MCMANUS): Staff Director, W&M Health Subcommittee. LA, Rep. Bill Thomas.
TargetedSENATE · HOUSE OF REPRESENTATIVES · Centers For Medicare and Medicaid Services (CMS)
Health Issues
Advocating for access to biosimilars.
LobbyistsJOHN MCMANUS · ms LAWREN D GEER · ALEX WHALEN
TargetedSENATE · HOUSE OF REPRESENTATIVES
